|
Volumn 133, Issue 12, 2000, Pages 999-1001
|
Hormones to prevent coronary disease in women: When are observational studies adequate evidence?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
ESTROGEN;
GESTAGEN;
PLACEBO;
AGED;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CORONARY RISK;
DOUBLE BLIND PROCEDURE;
ESTROGEN THERAPY;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
HYPERLIPIDEMIA;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STROKE;
TREATMENT OUTCOME;
|
EID: 0034687855
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-133-12-200012190-00016 Document Type: Review |
Times cited : (30)
|
References (17)
|